Brief: Tilray Medical Announces Major Expansion Of Medical Cannabis Portfolio In Australia
March 19 (Reuters) - Tilray Brands Inc TLRY.TO: TILRAY MEDICAL ANNOUNCES MAJOR EXPANSION OF MEDICAL CANNABIS PORTFOLIO IN AUSTRALIA Source text: ID:nGNX7w88Bg Further company coverage: TLRY.TO ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Tilray Brands
See all newsCannabis firm Tilray's Q1 revenue rises 82% on BrewDog acquisition
Brief: Tilray Brands Q1 Revenue USD 257.147 Million
Brief: 10 Barrel Expands Salty Sips Rtd Portfolio With New Blackberry Refresher
Tilray Q4 revenue rises 25% on the back of international medical cannabis
Brief: Tilray Brands Q4 Revenue USD 281.714 Million